Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
Open Access
- 17 January 2020
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 45 (3) , 750-758
Abstract
Purpose: To assess the role of CT-texture analysis (CTTA) for differentiation of pancreatic ductal adenocarcinoma (PDAC) from pancreatic neuroendocrine neoplasm (PNEN) in the portal-venous phase as compared with visual assessment and tumor-to-pancreas attenuation ratios. Methods: 53 patients (66.1 ± 8.6y) with PDAC and 42 patients (65.5 ± 12.2y) with PNEN who underwent contrast-enhanced CT for primary staging were evaluated. Volumes of interests (VOIs) were set in the tumor tissue at the portal-venous phase excluding adjacent structures. Based on pyradiomics library, 92 textural features were extracted including 1st, 2nd, and higher order features, and then compared between PNEN and PDAC. The visual assessment classified tumors into hypo-, iso-, or hyperdense to pancreas parenchyma or into homogeneous/heterogeneous. Additionally, attenuation ratios between the tumors and the non-involved pancreas were calculated. Results: 8/92 (8.6%) highly significant (p < 0.005) discriminatory textural features between PDAC and PNEN were identified including the 1st order features “median,” “total energy,” “energy,” “10th percentile,” “90th percentile,” “minimum,” “maximum,” and the 2nd order feature “Gray-Level co-occurrence Matrix (GLCM) Informational Measure of Correlation (Imc2).” In PNEN, the higher order feature “GLSZM Small Area High Gray-Level Emphasis” proved significantly higher in G1 compared to G2/3 tumors (p < 0.05). The tumor/parenchyma ratios as well as the visual assessment into hypo-/iso-/hyperdense or homogeneous/heterogeneous did not significantly differ between PDAC and PNEN. Conclusions: Our data indicate that CTTA is a feasible tool for differentiation of PNEN from PDAC and also of G1 from G2/3 PNEN in the portal-venous phase. Visual assessment and tumor-to-parenchyma ratios were not useful for discrimination.Keywords
This publication has 30 references indexed in Scilit:
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Pancreatic Imaging Mimics: Part 2, Pancreatic Neuroendocrine Tumors and Their MimicsAmerican Journal of Roentgenology, 2012
- Pancreatic Imaging Mimics: Part 1, Imaging Mimics of Pancreatic AdenocarcinomaAmerican Journal of Roentgenology, 2012
- Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weightsMagnetic Resonance Materials in Physics, Biology and Medicine, 2011
- Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors1Radiology, 2009
- Rosai and Ackerman's surgical pathology, 9th edition author: Juan Rosai Mosby, Edinburgh, 2004Diagnostic Cytopathology, 2006
- Endocrine tumours of the pancreasBest Practice & Research Clinical Gastroenterology, 2005
- Pancreatic Malignancy: Value of Arterial, Pancreatic, and Hepatic Phase Imaging with Multi–Detector Row CTRadiology, 2003
- Multi–Detector Row Helical CT of the Pancreas: Effect of Contrast-enhanced Multiphasic Imaging on Enhancement of the Pancreas, Peripancreatic Vasculature, and Pancreatic AdenocarcinomaRadiology, 2001
- Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT.American Journal of Roentgenology, 1999